Journal of Bone and Joint Infection
Journal of Bone and Joint Infection
JBJI
Articles | Volume 11, issue 4
Articles | Volume 11, issue 4
https://doi.org/10.5194/jbji-11-395-2026
© Author(s) 2026. This work is distributed under
the Creative Commons Attribution 4.0 License.
https://doi.org/10.5194/jbji-11-395-2026
© Author(s) 2026. This work is distributed under
the Creative Commons Attribution 4.0 License.
Articles | Volume 11, issue 4
Case report
 | 
06 Jul 2026
Case report |  | 06 Jul 2026

Literature review and case report on the use of rezafungin for spondylodiscitis in an outpatient parenteral antimicrobial therapy (OPAT) setting

Alexander J. Richards, Ammara Asif, Monica Ivan, Patrick J. Lillie, Gavin Barlow, and Chloe Walsh

Viewed

Total article views: 169 (including HTML, PDF, and XML)
HTML PDF XML Total BibTeX EndNote
111 46 12 169 7 13
  • HTML: 111
  • PDF: 46
  • XML: 12
  • Total: 169
  • BibTeX: 7
  • EndNote: 13
Views and downloads (calculated since 06 Jul 2026)
Cumulative views and downloads (calculated since 06 Jul 2026)

Viewed (geographical distribution)

Total article views: 136 (including HTML, PDF, and XML) Thereof 136 with geography defined and 0 with unknown origin.
Country # Views %
  • 1
1
 
 
 
 
Latest update: 30 Jul 2026
Download
Short summary
Fungal infection can be difficult to treat, requiring long periods of hospitalisation. Rezafungin is a promising new antifungal medication that can be used to treat complex, deep-seated fungal infection. We examine the reported use of rezafungin in managing fungal infection of the bones and joints in an outpatient setting. Our case helps to provide further experience in the use of rezafungin as a powerful tool in helping patients get out of hospital and avoid further admissions.
Read more
Share